Cargando…
A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of di...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328983/ https://www.ncbi.nlm.nih.gov/pubmed/32590807 http://dx.doi.org/10.1097/MD.0000000000020958 |
_version_ | 1783552828739944448 |
---|---|
author | Zhang, Jinhuan Huang, Xingxian Liu, Yongfeng He, Yuhai Yu, Haibo |
author_facet | Zhang, Jinhuan Huang, Xingxian Liu, Yongfeng He, Yuhai Yu, Haibo |
author_sort | Zhang, Jinhuan |
collection | PubMed |
description | BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of different forms of acupuncture therapies for POF. METHODS: Seven databases including PubMed, the Cochrane Library, Embase, Wanfang database, China National Knowledge Infrastructure database, VIP Chinese Science, and Chinese Biomedical Database were searched for randomized controlled trials (RCTs) of various acupuncture treatments for POF. This time spanned from the date of database inception to January 13, 2020. RevMan 5.3 was used to assess the bias risk of the studies. A NMA of the included studies was performed using Stata14.0. RESULTS: A total of 408 items were searched in this study, and finally this NMA included 16 RCTS, involving 1,307 patients. It showed that acupuncture (OR:1.35,95%1.24 to 1.47) has the best effectiveness among the four acupuncture (standardized mean difference [SMD]-16.30,95% −31.33 to −1.28) is the most effective and the best in reducing follicle-stimulating hormone levels among the four acupuncture treatments. Acupuncture (SMD 26.67,95%5.95 to 47.40) and acupoint embedding (SMD41.14,95%11.90 to 70.37) were ranked in the top 2 positions, in improving estradiol, whereas acupuncture (SMD-4.90,95% −8.10 to −1.70) was than acupoint embedding and HRT, in reducing luteinizing hormone level. In addition, our conclusions have not changed significantly after the sensitivity analysis. Protocol registration number: CRD42020150508. CONCLUSION: With clinical evidence summarized by NMA, it is observed that acupuncture is the most promising therapy for improving menopausal symptoms, decreasing serum follicle-stimulating hormone and luteinizing hormone level. Therefore, acupuncture could be effective for patients with POF, who are intolerant to the adverse effects of hormone replacement therapy or who would prefer non-drug therapies. Further multi-center and high-quality RCT studies should be conducted to make our conclusion more rigorous. |
format | Online Article Text |
id | pubmed-7328983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-73289832020-07-09 A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis Zhang, Jinhuan Huang, Xingxian Liu, Yongfeng He, Yuhai Yu, Haibo Medicine (Baltimore) 3800 BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of different forms of acupuncture therapies for POF. METHODS: Seven databases including PubMed, the Cochrane Library, Embase, Wanfang database, China National Knowledge Infrastructure database, VIP Chinese Science, and Chinese Biomedical Database were searched for randomized controlled trials (RCTs) of various acupuncture treatments for POF. This time spanned from the date of database inception to January 13, 2020. RevMan 5.3 was used to assess the bias risk of the studies. A NMA of the included studies was performed using Stata14.0. RESULTS: A total of 408 items were searched in this study, and finally this NMA included 16 RCTS, involving 1,307 patients. It showed that acupuncture (OR:1.35,95%1.24 to 1.47) has the best effectiveness among the four acupuncture (standardized mean difference [SMD]-16.30,95% −31.33 to −1.28) is the most effective and the best in reducing follicle-stimulating hormone levels among the four acupuncture treatments. Acupuncture (SMD 26.67,95%5.95 to 47.40) and acupoint embedding (SMD41.14,95%11.90 to 70.37) were ranked in the top 2 positions, in improving estradiol, whereas acupuncture (SMD-4.90,95% −8.10 to −1.70) was than acupoint embedding and HRT, in reducing luteinizing hormone level. In addition, our conclusions have not changed significantly after the sensitivity analysis. Protocol registration number: CRD42020150508. CONCLUSION: With clinical evidence summarized by NMA, it is observed that acupuncture is the most promising therapy for improving menopausal symptoms, decreasing serum follicle-stimulating hormone and luteinizing hormone level. Therefore, acupuncture could be effective for patients with POF, who are intolerant to the adverse effects of hormone replacement therapy or who would prefer non-drug therapies. Further multi-center and high-quality RCT studies should be conducted to make our conclusion more rigorous. Wolters Kluwer Health 2020-06-26 /pmc/articles/PMC7328983/ /pubmed/32590807 http://dx.doi.org/10.1097/MD.0000000000020958 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3800 Zhang, Jinhuan Huang, Xingxian Liu, Yongfeng He, Yuhai Yu, Haibo A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title | A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title_full | A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title_fullStr | A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title_full_unstemmed | A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title_short | A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis |
title_sort | comparison of the effects of chinese non-pharmaceutical therapies for premature ovarian failure: a prisma-compliant systematic review and network meta-analysis |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328983/ https://www.ncbi.nlm.nih.gov/pubmed/32590807 http://dx.doi.org/10.1097/MD.0000000000020958 |
work_keys_str_mv | AT zhangjinhuan acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT huangxingxian acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT liuyongfeng acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT heyuhai acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT yuhaibo acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT zhangjinhuan comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT huangxingxian comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT liuyongfeng comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT heyuhai comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis AT yuhaibo comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis |